Hospital Departamental de Villavicencio
Villavicencio, Meta Department, 50001, Colombia
Location contact
Emma Rodriguez Darabos, MSc
CONTACT
Norton Perez, MD
CONTACT
Norton Perez, MD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT07530653
This study will provide information on the quality of care in hemorrhagic shock of severe injuries in a limited resource facility of Latin America, the strategies of fluid resuscitation, and outcomes.
Trial opening soon.
Get Notified18 year–100 year
All sexes
Observational
Villavicencio, Meta Department, 50001, Colombia
Emma Rodriguez Darabos, MSc
CONTACT
Norton Perez, MD
CONTACT
Norton Perez, MD
PRINCIPAL_INVESTIGATOR
Background / Introduction
Trauma remains a leading cause of mortality worldwide, particularly among young and economically productive populations, generating a disproportionate burden in terms of years of life lost, disability, and healthcare expenditures. Hemorrhagic shock is the most common cause of preventable death following trauma, especially within the first hours after injury. Despite advances in trauma systems and critical care, early mortality due to uncontrolled bleeding continues to pose a major clinical challenge.
Traditional resuscitation strategies have emphasized aggressive early fluid administration aimed at restoring normotension. However, growing evidence suggests that this approach may be physiologically detrimental in the setting of uncontrolled hemorrhage. Rapid volume expansion can dislodge forming clots, dilute coagulation factors, exacerbate acidosis, and contribute to the development of trauma-induced coagulopathy. These mechanisms are closely associated with the so-called "lethal triad" of trauma: hypothermia, acidosis, and coagulopathy, which significantly increases mortality risk.
In response to these concerns, the concept of delayed resuscitation, also referred to as permissive hypotension, has emerged as a damage control strategy. This approach aims to limit fluid administration until hemorrhage control is achieved, maintaining a lower-than-normal blood pressure sufficient for minimal organ perfusion while avoiding exacerbation of bleeding. Experimental models and clinical studies have suggested potential benefits, including reduced blood loss, lower transfusion requirements, and improved survival in selected patient populations.
However, the current body of evidence presents important limitations. Many studies have been conducted in high-resource settings with well-developed trauma systems, rapid surgical access, and availability of blood products. Furthermore, heterogeneity in study design, patient populations, injury patterns, and resuscitation protocols limits the generalizability of findings. Importantly, patients with traumatic brain injury, elderly individuals, and those with significant comorbidities may respond differently to hypotensive strategies, raising concerns regarding safety and applicability.
These uncertainties are particularly relevant in low- and middle-income countries (LMICs), including those in Latin America, where the burden of trauma is disproportionately high and healthcare systems often face resource constraints. In such settings, delays in definitive hemorrhage control, limited access to blood products, variability in prehospital care, and constrained intensive care capacity may influence both the feasibility and effectiveness of resuscitation strategies. Consequently, there is a critical need for context-specific evidence to guide clinical decision-making and optimize trauma care protocols in these environments.
Objective
To compare clinical outcomes in patients with hemorrhagic shock due to severe trauma according to the initial fluid resuscitation strategy, specifically delayed (permissive hypotension) versus immediate (conventional) resuscitation, in low-resource healthcare settings in Latin America.
Methods Study Design
This study is designed as a prospective, observational, analytical cohort study conducted in one or more tertiary-level trauma centers in Latin America. The study will adhere to STROBE guidelines for observational research.
Study Population
Eligible participants will include adult patients (≥18 years) presenting with severe trauma and clinical evidence of hemorrhagic shock. Hemorrhagic shock will be defined using a combination of clinical and laboratory criteria, including systolic blood pressure <90 mmHg, elevated lactate levels, base deficit, and/or clinical signs of hypoperfusion.
Inclusion criteria
Adult patients with major trauma (Injury Severity Score ≥15) Evidence of active bleeding or suspected hemorrhagic shock Admission within a defined time window from injury Exclusion Criteria Severe traumatic brain injury requiring strict blood pressure targets Cardiac arrest prior to hospital arrival Pregnant patients Patients with advanced directives limiting care Exposure Definition
Patients will be categorized based on the initial resuscitation strategy:
Delayed resuscitation group: restricted fluid administration prior to hemorrhage control, targeting permissive hypotension (e.g., systolic blood pressure 80-90 mmHg or presence of radial pulse) Immediate resuscitation group: standard aggressive fluid resuscitation aiming to restore normotension Data Collection
Data will be collected prospectively using standardized case report forms and will include:
Demographic characteristics Mechanism and severity of injury Prehospital and emergency department interventions Hemodynamic parameters and laboratory values Volume of fluids and blood products administered Time to hemorrhage control Outcomes Primary Outcome In-hospital mortality Secondary Outcomes 24-hour mortality Blood product utilization Development of complications (e.g., acute respiratory distress syndrome, multiple organ dysfunction syndrome, acute kidney injury) Length of stay in intensive care unit and hospital Need for surgical or interventional procedures Statistical Analysis
Descriptive statistics will be used to summarize baseline characteristics. Comparisons between groups will be performed using appropriate statistical tests (Chi-square, t-test, or Mann-Whitney U test). Multivariable logistic regression models will be constructed to evaluate the association between resuscitation strategy and outcomes, adjusting for potential confounders such as injury severity, age, mechanism of trauma, and comorbidities.
Propensity score methods may be employed to reduce selection bias and improve comparability between groups. Sensitivity analyses will be conducted to assess robustness of findings.
Expected Results
It is hypothesized that delayed resuscitation will be associated with:
Reduced in-hospital mortality Lower transfusion requirements Decreased incidence of complications related to fluid overload and coagulopathy
However, potential risks, including inadequate organ perfusion and adverse outcomes in specific subgroups, will also be critically evaluated.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Administration of IV fluids below 1,000 mL on prehospital care.
Other names: Restricted IV fluids, Permissive hypotension
Prehospital IV fluids more than 1,000 mL.
Other names: High volume resuscitation
Time frame: 28 days
Mortality on discharge or before 28 days.
Time frame: 24 hours.
Mortality in the ICU or within 24 hours of admission.
Time frame: 24 hours.
Bleeding times prolonged > 1.5 times.
Contact information is provided by the study sponsor or research team.
Emma I Rodriguez Darabos, MSc
CONTACT
Norton Perez, MD
CONTACT
Hospital Departamental de Villavicencio
Other
Delayed Resuscitation in Hemorrhagic Shock Due to Severe Injuries of the Torso in Low-resource Facilities of Latin America.
Acronym: PERMIT-LATAM
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07252505
Trauma and Emergency Care, Wounds and Injuries
View Trial DetailsNCT04763746
Cardiovascular Diseases, Critical Care
Portsmouth, England, United Kingdom
View Trial DetailsNCT07218185
Afibrinogenemia, Blood Coagulation Disorders
Aurora, Colorado, United States
View Trial DetailsNCT05958342
Diabetes Insipidus, Endocrine System Diseases
Tucson, Arizona, United States
View Trial Details